• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SIERRA; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1500400-15
Device Problems Patient-Device Incompatibility (2682); Migration (4003)
Patient Problem Foreign Body In Patient (2687)
Event Date 10/22/2019
Event Type  Injury  
Manufacturer Narrative
Exemption number (b)(4)-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.Na.
 
Event Description
It was reported the procedure was to treat a heavily tortuous and moderately calcified lesion in the left main (lm).The 4.0x15mm rx xience sierra stent delivery system (sds) was advanced to the lesion and the stent deployed.It was noted the stent was not well apposed to the vessel wall and migrated to the iliac artery.The stent was not retrieved and remains in the iliac artery.There was no clinically significant delay in the procedure and no adverse patient sequela.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.The reported migration and wall apposition could not be replicated in testing environment as it was related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation was unable to determine a conclusive cause for the reported patient device incompatibility (wall apposition).The reported stent migration appears to be related to operational context of the procedure as it is the reported wall apposition caused the reported stent migration.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SIERRA
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9250173
MDR Text Key164118397
Report Number2024168-2019-13005
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 01/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/29/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/09/2021
Device Catalogue Number1500400-15
Device Lot Number8110642
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/02/2019
Date Manufacturer Received01/27/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
RUNTHROUGH GUIDE WIRE.; RUNTHROUGH GUIDE WIRE
Patient Outcome(s) Other;
-
-